Then along came Variant Bio, whose mission it is “to leverage the power of human genetic diversity to develop life-saving therapies.” As far as I could tell, it was — and remains to this day — a real outlier in the biopharma world. From the moment it was founded, leaders at Variant Bio set about figuring out how to integrate community-engaged research and benefit-sharing policies into their business model. They formed an ethics advisory board before even a scientific advisory board, and they hired anthropologists right out of the gate. Taking as guidepost the Indigenous data sovereignty movement, Variant Bio built out a unique approach to benefit sharing that aims to increase equity in genomics, and to prioritize the perspectives of the communities who participate in research with us.
Title: Advancements Transforming Medical Research and Healthcare
In the realm of medical research and healthcare, breakthroughs continually reshape our understanding and treatment of diseases, revolutionizing patient care and outcomes. From innovative technologies…